Rivaroxaban Hypericum Trial

NCT03796377 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Drug Interaction Study

Interventions

DRUG: St Johns Wort Extract
DRUG: Rivaroxaban

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]